You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal

Showing 26 - 50 of 8,846
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment

Recruiting
  • COVID-19 Convalescent Plasma Treatment
    • Strasbourg, France
      Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
    Jun 15, 2023

    Healthy Trial in Qingdao (VDJ001, Placebo)

    Completed
    • Healthy
    • Qingdao, Shandong, China
      the Affliated Hospital of Qingdao University
    Aug 30, 2023

    Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
    Jan 30, 2023

    Medicare Anti-Aß mAb Coverage With Evidence Development Study

    Recruiting
    • Mild Alzheimer's Disease
    • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
    • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
    • Baltimore, Maryland
      Centers for Medicare and Medicaid Services
    Sep 21, 2023

    Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)

    Active, not recruiting
    • Psoriasis
    • Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
    • Placebo
    • Shanghai, Shanghai, China
    • +2 more
    Nov 7, 2022

    COVID-19 Trial in Joondalup (VYD222, Placebo)

    Recruiting
    • COVID-19
    • Joondalup, Western Australia, Australia
      Linear Clinical Research
    Apr 3, 2023

    Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

    Completed
    • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
    • Wenzhou, Zhejiang, China
      The First Affiliated Hospital of Wenzhou Medical University
    Nov 6, 2023

    Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

    Active, not recruiting
    • Pyoderma
    • +3 more
    • Monoclonal antibody (Mab) sB24M
    • Minsk, Belarus
    • +1 more
    Jul 8, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Necitumumab
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jan 5, 2023

    Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

    Recruiting
    • Migraine
    • Head Pain
      • Valladolid, Spain
        Hospital Clínico Universitario de Valladolid
      Mar 23, 2023

      Lymphoma Trial (BYON4228 + Rituximab)

      Not yet recruiting
      • Lymphoma
      • BYON4228 + Rituximab
      • (no location specified)
      Feb 20, 2023

      Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

      Not yet recruiting
      • Primary Immune Thrombocytopenia (ITP)
      • TPO-RAs
      • TPO-RAs combining anti-CD 20 monoclonal antibody
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital, Chinese Aca
      Feb 7, 2023

      Alzheimer Trial (Lecanemab)

      Not yet recruiting
      • Alzheimer Disease
      • (no location specified)
      Jun 22, 2023

      Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)

      Not yet recruiting
      • Alzheimer Disease
      • Anti-amyloid Monoclonal Antibodies (mAbs)
      • Standard of Care
      • Albany, Georgia
      • +7 more
      Aug 13, 2023

      COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

      Suspended
      • COVID-19 Infection
      • +2 more
      • Questionnaire Administration
      • Sotrovimab
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 24, 2023

      Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

      Recruiting
      • Metastatic Salivary Gland Carcinoma
      • +4 more
      • New York, New York
        Memorial Sloane Kettering Cancer Center
      Jan 11, 2023

      Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

      Completed
      • Clostridium Infection
      • Collection of peripheral blood mononuclear cells
      • Paris, France
        Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
      Oct 3, 2022

      Allergic Rhinitis Trial in Wuhan (GR1802 injection-1, GR1802 injection-2, Placebo)

      Recruiting
      • Allergic Rhinitis
      • GR1802 injection-1
      • +2 more
      • Wuhan, Hubei, China
        Tongji Hosptial affiliated to Tongji Medical college of Huazhong
      Sep 7, 2023

      Colorectal Cancer Trial in New York (mAb hu3S193)

      Terminated
      Has Results
      • Colorectal Cancer
      • monoclonal antibody hu3S193
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Oct 3, 2022

      Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

      Not yet recruiting
      • Long COVID
      • +2 more
      • San Francisco, California
        UCSF/Zuckerberg San Francisco General Hospital
      Jun 2, 2023

      Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,

      Recruiting
      • Advanced Lung Carcinoma
      • LK101 injection (personlized neoantigen pulsed DC vaccine )
      • +2 more
      • Beijing, Beijing, China
        Cancer hospital Chinese Academy of Medical Sciences
      May 23, 2023

      NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

      Not yet recruiting
      • NK-T-Cell Lymphoma, Extranodal
      • 4 cycles of ESA regimen with sandwiched radiotherapy
      • +2 more
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Sep 29, 2023

      IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With

      Not yet recruiting
      • Chronic Rhino-sinusitis
      • +3 more
      • IL-4R
      • Placebo
      • Beijing, Beijing, China
        Beijing Tongren Hospital, Capital Medical University
      Jun 17, 2022

      Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

      Not yet recruiting
      • Thyroid Eye Disease
      • VRDN-001 10 mg/kg Drug:
      • (no location specified)
      Sep 7, 2023

      Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

      Recruiting
      • Safety and Efficacy
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 27, 2023